naltrexone has been researched along with Brain Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, N; Hiraoka, M; Ishida, M; Ishiguro, T; Itoga, T; Onishi, H; Sugano, K; Yaguchi, A | 1 |
| Brenner, DM; Coluzzi, PH; Israel, RJ; Slatkin, NE; Stambler, N | 1 |
| Feng, ZP; Rutka, JT; Sun, HS; Turlova, E; Wong, R | 1 |
| Kast, RE | 1 |
| Heintz, J; Kissling, KT; Mohassel, LR | 1 |
| Elliott, J; Lambert, DG; Smart, D; Traynor, JR | 1 |
| Lee, YS; Wurster, RD | 1 |
| Barigozzi, P; Barni, S; Fossati, V; Frigerio, F; Lissoni, P; Meregalli, S; Tancini, G | 1 |
| Barg, J; Belcheva, MM; Coscia, CJ; Johnson, FE; Levy, R; McHale, RJ; McLachlan, JA; Vogel, Z | 1 |
| Altememi, GF; Mandyam, CD; Standifer, KM | 1 |
1 review(s) available for naltrexone and Brain Neoplasms
| Article | Year |
|---|---|
Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma.
Topics: Brain Neoplasms; Central Nervous System Stimulants; Drug Approval; Drug Synergism; Glioblastoma; Humans; Methamphetamine; Naltrexone; Narcotic Antagonists; Neovascularization, Pathologic; Quaternary Ammonium Compounds; United States; United States Food and Drug Administration; Vascular Endothelial Growth Factor A | 2009 |
2 trial(s) available for naltrexone and Brain Neoplasms
| Article | Year |
|---|---|
The influence of brain metastases on the central nervous system effects of methylnaltrexone: a post hoc analysis of 3 randomized, double-blind studies.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Brain Neoplasms; Central Nervous System; Constipation; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Quaternary Ammonium Compounds | 2021 |
Radioendocrine therapy of brain tumors with the long acting opioid antagonist naltrexone in association with radiotherapy.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Male; Middle Aged; Naltrexone; Pilot Projects; Remission Induction; Survival Analysis | 1993 |
7 other study(ies) available for naltrexone and Brain Neoplasms
| Article | Year |
|---|---|
Naldemedine-induced opioid withdrawal syndrome with severe psychiatric symptoms in an advanced cervical cancer patient without brain metastasis.
Topics: Adult; Analgesics, Opioid; Brain Neoplasms; Constipation; Female; Humans; Naltrexone; Narcotic Antagonists; Uterine Cervical Neoplasms | 2022 |
Activation of TRPM7 by naltriben enhances migration and invasion of glioblastoma cells.
Topics: Brain Neoplasms; Calcium; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Glioblastoma; Humans; Immunoblotting; Matrix Metalloproteinase 2; Membrane Potentials; Naltrexone; Neoplasm Invasiveness; Patch-Clamp Techniques; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TRPM Cation Channels | 2017 |
Methylnaltrexone for opioid-induced constipation in a pediatric oncology patient.
Topics: Analgesics, Opioid; Brain Neoplasms; Child; Constipation; Female; Humans; Morphine; Naltrexone; Narcotic Antagonists; Neuroblastoma; Pain; Quaternary Ammonium Compounds | 2012 |
Characterisation of mu-opioid receptors on SH-SY5Y cells using naloxonazine and beta-funaltrexamine.
Topics: Amino Acid Sequence; Animals; Brain Neoplasms; Cerebral Cortex; Diprenorphine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Humans; Ligands; Molecular Sequence Data; Naloxone; Naltrexone; Neuroblastoma; Rats; Receptors, Opioid, mu; Somatostatin; Tumor Cells, Cultured | 1994 |
Differential effects of methionine enkephalin on the growth of brain tumor cells.
Topics: Astrocytoma; Brain Neoplasms; Cell Division; Enkephalin, Methionine; Humans; Naltrexone; Neuroblastoma; Signal Transduction; Tumor Cells, Cultured | 1994 |
A monoclonal anti-idiotypic antibody to opioid receptors labels desipramine-induced opioid binding sites on rat C6 glioma cells and attenuates thymidine incorporation into DNA.
Topics: Animals; Antibodies, Monoclonal; Brain Neoplasms; Cell Division; Cell Membrane; Colorimetry; Densitometry; Desipramine; DNA, Neoplasm; Glioma; Immunohistochemistry; Morphine; Naltrexone; Pertussis Toxin; Rats; Receptors, Opioid; Thymidine; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1994 |
beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells.
Topics: Brain Neoplasms; Cyclic AMP; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Humans; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Neuroblastoma; Nociceptin; Nociceptin Receptor; Opioid Peptides; Receptors, Opioid; Receptors, Opioid, mu; Tumor Cells, Cultured | 2000 |